Document is current
Any future updates will be listed below
-
Authors
Valenzuela, Michael http://orcid.org/0000-0001-7162-6607
Duncan, T.
Abey, A.
Johnson, A.
Boulamatsis, C.
Dalton, M. A.
Jacobson, E.
Brunel, L.
Child, G.
Simpson, D.
Buckland, M.
Lowe, A.
Siette, J.
Westbrook, F.
McGreevy, P.
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council
- License Information
-
More Information
Article History
Received: 30 April 2022
Accepted: 1 June 2022
First Online: 17 June 2022
Declarations
:
: All animal studies were approved in advance by the corresponding local instutional animal ethics committee as detailed in Methods. Carers of all companion animals in the veterinary trial provided informed consent.
: Not applicable.
: This work commenced and developed academically by MV from 2012–2019 at the University of Sydney. In 2018, MV, TD and Dr An Truong invented new technology for manufacturing SKN-like cells from mature adult human skin; Skin2Neuron Pty Ltd was formed in 2019 to commercially develop this concept and fund ongoing research including the conclusion of this work. In 2020, Skin2Neuron acquired the IP and MV now serves the company as chief executive officer with a financial interest.
